![]() Kaya Holdings Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies. | ![]() Zynerba Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. | ||
Founding Date | Founding Date 2016 | Founding Date 1993 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations North Fort Myers, US HQ Bradenton, US Edgewater, US Jacksonville, US Miami, US Orlando, US Pensacola, US see more | Locations Fort Lauderdale, US HQ Kallithea, GR Tzur Yitzhak, IL | Locations Devon, US HQ |
Employees | Employees 4,455 | Employees 620% increase | Employees 2511% decrease |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 1 m | Valuation ($) 70.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $1.2b (FY, 2025) | Revenue (est.) $7.1k (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $470m (FY, 2025) | Cost of goods $7.5k (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit $711.2m (FY, 2025) | Gross profit ($366) (FY, 2024) | Gross profit N/A |
Net income | Net income ($122.2m) (FY, 2025) | Net income ($2.2m) (FY, 2024) | Net income ($35m) (FY, 2022) |

Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies.
View company
Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.
View company